Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion
详细信息 查看全文
- 关键词：Mesenchymal chondrosarcoma ; Pancreas ; HEY1-NCOA2 ; Gene fusion ; Biphasic
- 刊名：Human Pathology
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：58
- 期：Complete
- 页码：35-40
- 全文大小：1238 K
- 卷排序：58
文摘
Mesenchymal chondrosarcoma (MC) is an aggressive small, round, blue cell tumor with chondrogenic differentiation that typically arises in bony sites. Approximately, a third of these tumors develop in extraskeletal sites such as the meninges, and somatic soft tissue. The MCs are well-circumscribed, lobulated masses, with focal calcification. Histologically, 2 distinct populations of neoplastic cells characterize MC: sheets of primitive small, round, blue cells surrounding islands of well-developed hyaline cartilage with mature chondrocytes in lacunae. Involvement of the gastrointestinal tract and pancreas by primary or metastatic MC is a relatively rare occurrence. We identified 8 patients with MC in our departmental archives from 1990 to 2015, two of which had pancreatic involvement. The patients were young women who developed masses in the distal pancreas. Molecular testing demonstrated that both tumors harbored the recently described HEY1-NCOA2 gene fusion. These cases illustrate that pancreatic involvement can occur in MC, and the demonstration of HEY1-NCOA2 fusion can be helpful to confirm the diagnosis.